Background: Bipolar disorders (BD) are among the most severe mental disorders with first clinical signs and symptoms frequently appearing in adolescence and early adulthood. The long latency in clinical diagnosis (and subsequent adequate treatment) adversely affects the course of disease, effectiveness of interventions and health-related quality of life, and increases the economic burden of BD. Despite uncertainties about risk constellations and symptomatology in the early stages of potentially developing BD, many adolescents and young adults seek help, and most of them suffer substantially from symptoms already leading to impairments in psychosocial functioning in school, training, at work and in their social relationships. We aimed to identify subjects at risk of developing BD and investigate the efficacy and safety of early specific cognitive-behavioural psychotherapy (CBT) in this subpopulation. Methods/Design: EarlyCBT is a randomised controlled multi-centre clinical trial to evaluate the efficacy and safety of early specific CBT, including stress management and problem solving strategies, with elements of mindfulness-based therapy (MBT) versus unstructured group meetings for 14 weeks each and follow-up until week 78. Participants are recruited at seven university hospitals throughout Germany, which provide in- and outpatient care (including early recognition centres) for psychiatric patients. Subjects at high risk must be 15 to 30 years old and meet the combination of specified affective symptomatology, reduction of psychosocial functioning, and family history for (schizo)affective disorders. Primary efficacy endpoints are differences in psychosocial functioning and defined affective symptomatology at 14 weeks between groups. Secondary endpoints include the above mentioned endpoints at 7, 24, 52 and 78 weeks and the change within groups compared to baseline; perception of, reaction to and coping with stress; and conversion to full BD. Discussion: To our knowledge, this is the first study to evaluate early specific CBT in subjects at high risk for BD. Structured diagnostic interviews are used to map the risk status and development of disease. With our study, the level of evidence for the treatment of those young patients will be significantly raised.

While cognitive-behavioral therapy (CBT) is the most well-established treatment for binge-eating disorder (BED), little is known about process factors influencing its outcome. The present study sought to explore the assessment of therapist adherence, its course over treatment, and its associations with patient and therapist characteristics, and the therapeutic alliance. In a prospective multicenter randomized-controlled trial comparing CBT to internet-based guided self-help (INTERBED-study), therapist adherence using the newly developed Adherence Control Form (ACF) was determined by trained raters in randomly selected 418 audio-taped CBT sessions of 89 patients (25% of all sessions). Observer-rated therapeutic alliance, interview-based and self-reported patient and therapist characteristics were assessed. Three-level multilevel modeling was applied. The ACF showed adequate psychometric properties. Therapist adherence was excellent. While significant between-therapist variability in therapist adherence was found, within-therapist variability was non-significant. Patient and therapist characteristics did not predict the therapist adherence. The therapist adherence positively predicted the therapeutic alliance. The ACF demonstrated its utility to assess therapist adherence in CBT for BED. The excellent levels of therapist adherence point to the internal validity of the CBT within the INTERBED-study serving as a prerequisite for empirical comparisons between treatments. Variability between therapists should be addressed in therapist trainings and dissemination trials.

Clinicians frequently treat patients suffering from more than one mental disorder. As they have to choose which disorder to treat first, knowledge on generalization effects or even comorbidity-associated obstacles should guide the clinician’s decision. Patients with panic disorder (PD) and agoraphobia (AG) often suffer from other mental disorders, e.g. social anxiety disorder (SAD) [1]. Nevertheless, evidence is missing whether cognitive-behavioral therapy (CBT) for PD/AG generalizes to SAD or whether comorbid SAD impedes the treatment of primary PD/AG.

Severe motor vehicle accidents (MVAs) represent one of the most often occurring psychological traumas, and are a leading cause of Posttraumatic Stress Disorder (PTSD). However, not all persons develop PTSD after traumatic events and a great proportion of patients who show symptoms initially recover over time. This has stimulated research of psychological and biological factors that explain development and maintenance of the disorder. Fortunately, this highly distressing condition can be effectively treated, e.g. via cognitive behavioral therapy (CBT). However, brain mechanisms underlying changes due to psychological therapy in PTSD are almost unknown (Roffman, Marci, Glick, Dougherty, & Rauch, 2005). On the other hand there are observations of positive changes following trauma called Posttraumatic Growth (PTG), which have stimulated research of associated psychological processes and factors. However, there is a lack of research about the relation of biological variables (e.g. measures of brain function) and PTG. Theories of brain asymmetry and emotion (Davidson, 1998b, 2004b; Heller, Koven, & Miller, 2003) propose that asymmetries of brain activation are related to certain features of human emotion (e.g. valence, approach or withdrawal tendencies, arousal). Whereas an enormous increase in the understanding of structural and functional abnormalities in PTSD could be achieved in the last decades due to neuroimaging research, there are still numerous unanswered questions. Especially, there is only little research explicitly examining activation asymmetries in PTSD. Furthermore, as mentioned, research is sparse investigating alterations of brain function that are associated with successful psychological treatment of PTSD. Finally, there is no published study examining how measures of brain function are related to PTG. This thesis presents 3 studies investigating electroencephalographic (EEG) asymmetries in survivors of severe motor vehicle accidents. The first part of the thesis (chapter 2) is devoted to a literature review about description (chapter 2.1), epidemiology (chapter 2.2 and 2.3), risk factors (chapter 2.4), psychological theories (chapter 2.5), biological mechanisms particularly neuroimaging findings (chapter 2.6), and treatment of PTSD (chapter 2.7.). Chapter 2.8 gives a short review on definition and research of Posttraumatic Growth. Chapter 2.9 provides an overview of models and research regarding brain asymmetry and emotion. In chapter 3.1, a study is presented that investigated hemispheric asymmetries (EEG alpha) among MVA survivors with PTSD, with subsyndromal PTSD, and without PTSD as well as non-exposed healthy controls during a baseline condition and in response to neutral, positive, negative, and trauma-related pictures (study I). Next, the findings of study II are presented (chapter 3.2). This study examined the effect of cognitive behavioral therapy on measures of EEG activity. Therefore, EEG activity before and after CBT in comparison to an assessment only Wait-list condition was measured. In chapter 3.3 a correlational study (study III) is presented that examined the relationship between frontal brain asymmetry and selfreported posttraumatic growth after severe MVAs. Finally, in chapter 4 the findings are summarized and discussed with respect to (1) the state/trait debate in frontal asymmetry research and (2) current psychological theories of PTSD and PTG. In addition, the use of neuroscientific research for psychotherapy is discussed. Suggestions are presented for future goals for “brain” research of PTSD and treatment of PTSD. / Schwere Verkehrsunfälle stellen eines der am häufigsten vorkommenden psychologischen Traumata dar, und sind eine Hauptursache der Posttraumatischen Belastungsstörung (PTBS). Jedoch entwickeln nicht alle Personen nach traumatischen Ereignissen eine PTBS und bei einem Großteil remittieren anfängliche PTBS-Symptome. Dies stimulierte die Erforschung von psychologischen und biologischen Faktoren, die die Entstehung und Aufrechterhaltung der PTBS erklären. Glücklicherweise kann die PTBS effektiv, z.B über die kognitive Verhaltenstherapie (KVT), behandelt werden. Jedoch sind Gehirnmechanismen, die mit klinischen Änderungen aufgrund der psychologischen Therapie in PTSD einhergehen, nahezu unbekannt (Roffman, Marci, Glick, Dougherty, Rauch, 2005). Auf der anderen Seite gibt es Berichte von positiven Änderungen nach traumatischen Ereignissen, die als Posttraumatische Reifung (PTR) bezeichent werden. Dies hat in kürzerer Vergangenheit die Forschung von verbundenen psychologischen Prozessen und Faktoren stimuliert. Jedoch gibt es kaum Untersuchungen über die Beziehung von biologischen Variablen (z.B Messungen der Gehirnfunktion) und PTR. Diese Arbeit präsentiert 3 Studien, die electroenzephalographische (EEG) Asymmetrien bei Opfern schwerer Verkehrsunfälle untersuchten. Der erste Teil der Arbeit (Kapitel 2) widmet sich einer Literaturrezension über: die Beschreibung (Kapitel 2.1), Epidemiologie (Kapitel 2.2 und 2.3), Risikofaktoren (Kapitel 2.4), psychologische Theorien (Kapitel 2.5), biologische Mechanismen besonders Neuroimaging Ergebnisse (Kapitel 2.6), und Behandlung der PTBS (Kapitel 2.7.). Kapitel 2.8 gibt einen kurzen Überblick über die Definition und Forschung zur Posttraumatischen Reifung. Kapitel 2.9 gibt eine Übersicht zu aktuellen Modellen und empirischen Befunden bezüglich Gehirnasymmetrien und Emotionen. Kapitel 3.1 präsentiert eine Studie, in der hemisphärische Asymmetrien (im EEG-Alpha Band) bei Unfallopfern mit PTBS, subsyndromaler PTBS, und ohne PTBS sowie gesunden Kontrollpersonen ohne Unfall untersucht wurden: während einer Ruhemessung und einer Emotionsinduktions-bedingung (neutrale, positive, negative und trauma-spezifische Bilder) (Studie I). Danach werden die Ergebnisse der Studie II (Kapitel 3.2) präsentiert. Hier wurde die Wirkung der kognitiven Verhaltenstherapie auf Messungen der EEG-Aktivität untersucht. Deshalb wurde EEG-Aktivität vor und nach einer KVT im Vergleich mit einer Warten-Gruppe gemessen. Kapitel 3.3 präsentiert eine Korellationsanalyse (Studie III), bei der die Beziehung zwischen der frontalen Gehirnasymmetrie und posttraumatischer Reifung untersucht wurde. Am Ende der Arbeit (Kapitel 4) werden die Ergebnisse zusammengefasst und in Bezug auf (1) die state/trait-Debatte im Rahmen der Asymmetrie-Forschung diskutiert sowie (2) ein Bezug zu aktuellen psychologische Theorien von PTSD und PTG hergestellt. Außerdem wird der Nutzen von neurobiologischer Forschung für die Psychotherapie besprochen. Dabei werden Vorschläge für zukünftige Projekte für die "Gehirn"-Forschung im Zusammenhang mit der PTBS, deren Behandlung und PTG gemacht.

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.

No description available.